B.R.I.D.G.E. TO DATA has been very helpful for initial screening data sources for a potential epi study. It provides broad, thorough, and detailed information on each database listed in the system.  It has been a wonderful tool to have, especially for feasibility evaluation.

I learned from my own experience that both in academia and pharmaceutics, prompt identification and selection of an adequate database is very important. In an academic setting, analyzing data from registries is particularly of great advantage in countries with limited financial resources for research which requires significant investment. In pharmaceuticals there is an increasing request from regulatory authorities for companies to conduct post-authorization safety studies. B.R.I.D.G.E.

The compendium maintained by BTD is a unique one with descriptions of databases from all over the world. Databases are described in a uniform way allowing fast comparison and selection of a database of interest.  BTD also has contact details of individuals responsible for maintaining the database. It is user friendly and has video tutorials that provide a potential user with a short and comprehensive training on how to navigate through the profiles.

I highly recommend researchers in the field of pharmacoepidemiology, pharmacoeconomics, and related disciplines to use BTD to identify a suitable database which will meet the needs of their research. Also, pharmaceutical companies should look more often at the databases described by BTD if they are required to conduct PASS studies, or for those in medical affairs or clinical science who need additional information.

This "database" of databases is very useful in my day-to-day activities as it allows me to find quickly which databases will fit the best regarding the research questions I have. It is very complete and contains information on countries for which it is sometimes difficult to find information elsewhere.